Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.

And Texas, spurred by a crusading longtime former governor, has the upper hand in bringing Ibogaine to the United States.

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep, they stop ...

Between Amazon’s Big Spring Sale and Walmart’s Spring Savings Sale, merchants are trying to make spring sales a thing—and ...

Listen… We are always on the hunt for a deal. Clothes, restaurants, travel, whatever — if there’s a deal out there, we’ll ...

Kim Kardashian has discovered a clever way to upgrade her daily routine, and now you can join this home revolution too.

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is upgraded to a Buy.

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.